1. Home
  2. IOVA
  3. IOVA News

Latest Iovance Biotherapeutics Inc. (IOVA) News on October 7, 2025

Iovance Biotherapeutics, Inc. (IOVA) Targeting $1B on Amtagvi Sales amid Cost Cuts
IOVA

Insider Monkey

18 days ago

Iovance Biotherapeutics, Inc. (IOVA) Targeting $1B on Amtagvi Sales amid Cost Cuts

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

18 days ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics (NasdaqGM:IOVA) Announces CFO Resignation
IOVA

Simply Wall St.

3 months ago

Iovance Biotherapeutics (NasdaqGM:IOVA) Announces CFO Resignation

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Gene Therapy Stocks Fall Amid More Turmoil at FDA
IOVA

Barrons.com

4 months ago

Gene Therapy Stocks Fall Amid More Turmoil at FDA

IOVA

MT Newswires

4 months ago

Iovance Biotherapeutics CFO Jean-Marc Bellemin to Depart

Iovance Biotherapeutics to Present at Upcoming Conference
IOVA

GlobeNewswire

4 months ago

Iovance Biotherapeutics to Present at Upcoming Conference

The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma
IOVA

GlobeNewswire

4 months ago

The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma

Iovance Presents Five-Year Amtagvi Data at ASCO for Advanced Melanoma
IOVA

Insider Monkey

4 months ago

Iovance Presents Five-Year Amtagvi Data at ASCO for Advanced Melanoma

Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
IOVA

GlobeNewswire

4 months ago

Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
IOVA

Motley Fool

5 months ago

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Down More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?
IOVA

Motley Fool

5 months ago

Down More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?

Why Iovance Biotherapeutics Tumbled by Nearly 6% Today
IOVA

Motley Fool

5 months ago

Why Iovance Biotherapeutics Tumbled by Nearly 6% Today

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics (NasdaqGM:IOVA) Faces Legal Action Amid Revenue Guidance Cut
IOVA

Simply Wall St.

5 months ago

Iovance Biotherapeutics (NasdaqGM:IOVA) Faces Legal Action Amid Revenue Guidance Cut

IOVA

MT Newswires

5 months ago

UBS Downgrades Iovance Biotherapeutics to Neutral From Buy, Adjusts Price Target to $2 From $17

Is This Beaten-Down Stock a Buy Near Its 52-Week Low?
IOVA

Motley Fool

5 months ago

Is This Beaten-Down Stock a Buy Near Its 52-Week Low?

Why Iovance Biotherapeutics (IOVA) Is Among the Best Low Priced Biotech Stocks to Buy Now
IOVA

Insider Monkey

5 months ago

Why Iovance Biotherapeutics (IOVA) Is Among the Best Low Priced Biotech Stocks to Buy Now

Need To Know: Analysts Just Made A Substantial Cut To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Estimates
IOVA

Simply Wall St.

5 months ago

Need To Know: Analysts Just Made A Substantial Cut To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Estimates

IOVA

MT Newswires

5 months ago

Truist Downgrades Iovance Biotherapeutics to Hold From Buy, After Q1 Sales Miss, Guidance Cut

3 Monster Stocks in the Making
IOVA

Motley Fool

5 months ago

3 Monster Stocks in the Making

Iovance Biotherapeutics First Quarter 2025 Earnings: Misses Expectations
IOVA

Simply Wall St.

5 months ago

Iovance Biotherapeutics First Quarter 2025 Earnings: Misses Expectations

IOVA

MT Newswires

5 months ago

Top Midday Decliners

IOVA

MT Newswires

5 months ago

Sector Update: Health Care Stocks Softer Friday Afternoon

Iovance Biotherapeutics Stock Sinks 46%. Here’s Why the Biotech Is Tumbling.
IOVA

Barrons.com

5 months ago

Iovance Biotherapeutics Stock Sinks 46%. Here’s Why the Biotech Is Tumbling.

Why Iovance Biotherapeutics Stock Is Crashing Today
IOVA

Motley Fool

5 months ago

Why Iovance Biotherapeutics Stock Is Crashing Today

IOVA

MT Newswires

5 months ago

Sector Update: Health Care Stocks Flat to Higher Premarket Friday

IOVA

MT Newswires

5 months ago

Sector Update: Health Care

IOVA

MT Newswires

5 months ago

Baird Downgrades Iovance Biotherapeutics to Neutral From Outperform, Adjusts Price Target to $3 From $20

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View Cut
IOVA

Zacks

5 months ago

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View Cut

IOVA

MT Newswires

5 months ago

Iovance Biotherapeutics Q1 Loss Narrows, Revenue Rises

Iovance Biotherapeutics Inc (IOVA) Q1 2025 Earnings Call Highlights: Strong Revenue from Antagy ...
IOVA

GuruFocus.com

5 months ago

Iovance Biotherapeutics Inc (IOVA) Q1 2025 Earnings Call Highlights: Strong Revenue from Antagy ...

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates
IOVA

Zacks

5 months ago

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Misses Revenue Estimates

IOVA

Associated Press Finance

5 months ago

Iovance Biotherapeutics: Q1 Earnings Snapshot

Iovance Biotherapeutics (NasdaqGM:IOVA) Sees 3% Price Increase Over Last Month
IOVA

Simply Wall St.

5 months ago

Iovance Biotherapeutics (NasdaqGM:IOVA) Sees 3% Price Increase Over Last Month

My 3 Favorite Stocks to Buy Right Now
IOVA

Motley Fool

5 months ago

My 3 Favorite Stocks to Buy Right Now

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Is Expected To Breakeven In The Near Future
IOVA

Simply Wall St.

5 months ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Is Expected To Breakeven In The Near Future

2 Beaten-Down Stocks With Incredible Upside Potential
IOVA

Motley Fool

5 months ago

2 Beaten-Down Stocks With Incredible Upside Potential

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.
IOVA

Motley Fool

5 months ago

Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.

This Biotech Stock Could Be the Best Investment of the Decade
IOVA

Motley Fool

6 months ago

This Biotech Stock Could Be the Best Investment of the Decade

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?
IOVA

Insider Monkey

6 months ago

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

6 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?
IOVA

Insider Monkey

6 months ago

Is Iovance Biotherapeutics Inc. (NASDAQ:IOVA) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Is Iovance Biotherapeutics a Millionaire-Maker?
IOVA

Motley Fool

6 months ago

Is Iovance Biotherapeutics a Millionaire-Maker?

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple
IOVA

Insider Monkey

6 months ago

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
IOVA

Motley Fool

6 months ago

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction
IOVA

Simply Wall St.

6 months ago

Iovance Biotherapeutics (NasdaqGM:IOVA) Drops 10% Over The Week In Market Correction

Traws Pharma Announces Management Updates
IOVA

GlobeNewswire

6 months ago

Traws Pharma Announces Management Updates

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) The Top Penny Stock That Will Skyrocket?
IOVA

Insider Monkey

6 months ago

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) The Top Penny Stock That Will Skyrocket?

1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street
IOVA

Motley Fool

7 months ago

1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street

3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not
IOVA

Motley Fool

7 months ago

3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

7 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) the Most Oversold Penny Stocks to Buy According to Analysts?
IOVA

Insider Monkey

7 months ago

Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) the Most Oversold Penny Stocks to Buy According to Analysts?

Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?
IOVA

Motley Fool

7 months ago

Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?

Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance
IOVA

Simply Wall St.

7 months ago

Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance

Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan
IOVA

TipRanks

7 months ago

Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan

IOVA

MT Newswires

7 months ago

Chardan Cuts Price Target on Iovance Biotherapeutics to $30 From $34, Keeps Buy Rating

Iovance Biotherapeutics Full Year 2024 Earnings: EPS Misses Expectations
IOVA

Simply Wall St.

7 months ago

Iovance Biotherapeutics Full Year 2024 Earnings: EPS Misses Expectations

IOVA

MT Newswires

7 months ago

Truist Adjusts Price Target on Iovance Biotherapeutics to $15 From $25, Maintains Buy Rating

IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty
IOVA

Zacks

7 months ago

IOVA Q4 Earnings Beat, Stock Down on Looming Economic Uncertainty

IOVA

MT Newswires

7 months ago

Iovance Biotherapeutics Q4 Loss Narrows, Revenue Rises

Iovance Biotherapeutics Inc (IOVA) Q4 2024 Earnings Call Highlights: Strong Revenue and ...
IOVA

GuruFocus.com

7 months ago

Iovance Biotherapeutics Inc (IOVA) Q4 2024 Earnings Call Highlights: Strong Revenue and ...

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates
IOVA

Zacks

7 months ago

Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Tops Revenue Estimates

IOVA

Associated Press Finance

7 months ago

Iovance Biotherapeutics: Q4 Earnings Snapshot

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
IOVA

GlobeNewswire

7 months ago

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024

What's in Store for These 5 Biotech Stocks This Earnings Season?
IOVA

Zacks

7 months ago

What's in Store for These 5 Biotech Stocks This Earnings Season?

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

8 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know
IOVA

Zacks

8 months ago

Will Iovance Biotherapeutics (IOVA) Report Negative Earnings Next Week? What You Should Know

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
IOVA

GlobeNewswire

8 months ago

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025

High Growth Tech Stocks In The United States To Watch
IOVA

Simply Wall St.

8 months ago

High Growth Tech Stocks In The United States To Watch

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

8 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
IOVA

GlobeNewswire

8 months ago

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

What's Wrong With Iovance Biotherapeutics Stock?
IOVA

Motley Fool

8 months ago

What's Wrong With Iovance Biotherapeutics Stock?

Where Will Iovance Biotherapeutics Be in 5 Years?
IOVA

Motley Fool

8 months ago

Where Will Iovance Biotherapeutics Be in 5 Years?

Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts
IOVA

Motley Fool

8 months ago

Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts

Insider Stock Buying Reaches US$48.3m On Iovance Biotherapeutics
IOVA

Simply Wall St.

8 months ago

Insider Stock Buying Reaches US$48.3m On Iovance Biotherapeutics

Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
IOVA

Insider Monkey

9 months ago

Is Iovance Biotherapeutics (IOVA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

3 Stocks That Could Turn $1,000 Into $5,000 by 2030
IOVA

Motley Fool

9 months ago

3 Stocks That Could Turn $1,000 Into $5,000 by 2030

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

9 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

3 Mid-Cap Stocks That Could Take Off in 2025
IOVA

Motley Fool

9 months ago

3 Mid-Cap Stocks That Could Take Off in 2025

Exploring 3 High Growth Tech Stocks In The United States
IOVA

Simply Wall St.

9 months ago

Exploring 3 High Growth Tech Stocks In The United States

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
IOVA

Motley Fool

9 months ago

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today

Why Iovance Biotherapeutics Inc. (IOVA) Is Skyrocketing
IOVA

Insider Monkey

9 months ago

Why Iovance Biotherapeutics Inc. (IOVA) Is Skyrocketing

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

10 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These
IOVA

Motley Fool

10 months ago

If I Could Only Buy 3 Stocks in the Last Month of 2024, I'd Pick These

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
IOVA

Motley Fool

10 months ago

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

Prediction: This Stock Will Beat the Market in 2025
IOVA

Motley Fool

10 months ago

Prediction: This Stock Will Beat the Market in 2025

3 Monster Stocks to Hold for the Next 10 Years
IOVA

Motley Fool

10 months ago

3 Monster Stocks to Hold for the Next 10 Years

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63%
IOVA

Simply Wall St.

10 months ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63%

Is Iovance Biotherapeutics Stock a Millionaire Maker?
IOVA

Motley Fool

10 months ago

Is Iovance Biotherapeutics Stock a Millionaire Maker?

IOVA

MT Newswires

10 months ago

Iovance Biotherapeutics Names Raj Puri as Chief Regulatory Officer

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
IOVA

GlobeNewswire

10 months ago

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back
IOVA

Motley Fool

10 months ago

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back

Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds
IOVA

Insider Monkey

10 months ago

Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds

2 Innovative Stocks That Could Deliver Outsize Returns
IOVA

Motley Fool

a year ago

2 Innovative Stocks That Could Deliver Outsize Returns

Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
IOVA

Insider Monkey

a year ago

Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations
IOVA

Simply Wall St.

a year ago

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
IOVA

Simply Wall St.

a year ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year

Share on Social Networks: